Literature DB >> 27023478

Soluble intracellular adhesion molecule-1 and omentin-1 as potential biomarkers of subclinical atherosclerosis in hemodialysis patients.

Marija Kocijancic1, Zlatko Cubranic2, Bozidar Vujicic3, Sanjin Racki3, Stefica Dvornik4, Luka Zaputovic2.   

Abstract

PURPOSE: Atherosclerotic cardiovascular complications represent significant cause of mortality in hemodialysis (HD) patients. The aims of this study were to: (a) investigate association of sICAM-1, sVCAM-1, omentin-1 and other non-traditional risk factors with subclinical atherosclerosis; (b) examine the diagnostic value of these specific markers in the early detection of subclinical atherosclerosis; and (c) examine their role as predictors of mortality in group of patients with subclinical atherosclerosis on regular HD.
MATERIALS AND METHODS: Starting from November 2011, a cohort of 210 HD patients participated in this 3-year follow-up study. The subjects were divided into three groups according to the presence of atherosclerosis. Atherosclerotic disease was assessed by measuring carotid intima-media thickness (IMT). Samplings were withdrawn at baseline and thereafter every 12 months until the end of follow-up.
RESULTS: IMT showed weak correlation with sICAM-1 (r = 0.39, P = 0.001), sVCAM-1 (r = 0.27, P = 0.015) and omentin-1 (r = -0.25, P = 0.020), and also omentin-1 showed good correlation with parameters of systolic and diastolic function (r = 0.52, P = 0.001 and r = 0.51, P = 0.001). Multivariate analysis showed that sICAM-1 and sVCAM-1 concentrations were a strong independent correlate of IMT (P = 0.031 and P = 0.010, respectively). The Cox proportional analysis showed that sICAM-1 and omentin-1 concentrations were strong predictors of cardiovascular death (HR 1.85, CI 1.18-2.32, P = 0.021 and HR 4.14, CI 1.38-12.1, P = 0.004, respectively) and that serial measurements of these markers predict IMT progression (HR 1.98, 95 % CI 1.21-2.38, P < 0.002 and HR 2.91, 95 % CI 1.57-4.72, P < 0.001, respectively).
CONCLUSIONS: Our study demonstrated that sICAM-1 and omentin-1 levels are strong predictors of cardiovascular death in HD patients with subclinical atherosclerosis.

Entities:  

Keywords:  Adhesion molecules; Biomarkers; Hemodialysis; Intima-media thickness; Omentin-1

Mesh:

Substances:

Year:  2016        PMID: 27023478     DOI: 10.1007/s11255-016-1275-2

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  27 in total

1.  Carotid atherosclerosis is associated with inflammation and endothelial cell adhesion molecules in chronic haemodialysis patients.

Authors:  Aikaterini Papagianni; Michalis Kalovoulos; Dimitrios Kirmizis; Andreas Vainas; Anna-Maria Belechri; Efstathios Alexopoulos; Dimitrios Memmos
Journal:  Nephrol Dial Transplant       Date:  2003-01       Impact factor: 5.992

2.  Serum levels of omentin in end-stage renal disease patients.

Authors:  Aytekin Alcelik; Mehmet Tosun; Mehmet Fatih Ozlu; Mustafa Eroglu; Gulali Aktas; Eray Kemahli; Haluk Savli; Mehmet Yazici
Journal:  Kidney Blood Press Res       Date:  2012-07-17       Impact factor: 2.687

3.  C-reactive protein and prediction of 1-year mortality in prevalent hemodialysis patients.

Authors:  Jonathan Bazeley; Brian Bieber; Yun Li; Hal Morgenstern; Patricia de Sequera; Christian Combe; Hiroyasu Yamamoto; Martin Gallagher; Friedrich K Port; Bruce M Robinson
Journal:  Clin J Am Soc Nephrol       Date:  2011-08-25       Impact factor: 8.237

Review 4.  Omentin: a novel link between inflammation, diabesity, and cardiovascular disease.

Authors:  Bee K Tan; Raghu Adya; Harpal S Randeva
Journal:  Trends Cardiovasc Med       Date:  2010-07       Impact factor: 6.677

Review 5.  Traditional and non-traditional risk factors as contributors to atherosclerotic cardiovascular disease in end-stage renal disease.

Authors:  Qiang Yao; Roberto Pecoits-Filho; Bengt Lindholm; Peter Stenvinkel
Journal:  Scand J Urol Nephrol       Date:  2004

6.  Inflammation, malnutrition, and cardiac disease as predictors of mortality in hemodialysis patients.

Authors:  A Rashid Qureshi; Anders Alvestrand; José C Divino-Filho; Alberto Gutierrez; Olof Heimbürger; Bengt Lindholm; Jonas Bergström
Journal:  J Am Soc Nephrol       Date:  2002-01       Impact factor: 10.121

7.  Rapid Screening for Subclinical Atherosclerosis by Carotid Ultrasound Examination: The HAPPY (Heart Attack Prevention Program for You) Substudy.

Authors:  Shaanemeet Singh; Aslam Nagra; Puneet Maheshwari; Rajababu Panwar; Harvey Hecht; Takenori Fukumoto; Manish Bansal; David Panthagani; Georgeanne Lammertin; Ravi Kasliwal; Hemant Mishra; Leonard Hofstra; Mahendra Pratap Singh; Valentin Fuster; Partho P Sengupta; Jagat Narula
Journal:  Glob Heart       Date:  2013-06

8.  Circulating soluble intercellular adhesion molecule 1 and subclinical atherosclerosis: the Coronary Artery Risk Development in Young Adults Study.

Authors:  Myron D Gross; Suzette J Bielinski; Jose R Suarez-Lopez; Alex P Reiner; Kent Bailey; Bharat Thyagarajan; J Jeffrey Carr; Daniel A Duprez; David R Jacobs
Journal:  Clin Chem       Date:  2011-12-16       Impact factor: 8.327

Review 9.  Dyslipidemia in chronic kidney disease: an approach to pathogenesis and treatment.

Authors:  Vasilis Tsimihodimos; Evangelia Dounousi; Kostas C Siamopoulos
Journal:  Am J Nephrol       Date:  2008-07-09       Impact factor: 3.754

Review 10.  Subclinical atherosclerosis: what it is, what it means and what we can do about it.

Authors:  P P Toth
Journal:  Int J Clin Pract       Date:  2008-06-28       Impact factor: 2.503

View more
  11 in total

1.  The effects of vitamin D supplementation on proatherogenic inflammatory markers and carotid intima media thickness in subjects with metabolic syndrome: a randomized double-blind placebo-controlled clinical trial.

Authors:  Shabnam Salekzamani; Abolhassan Shakeri Bavil; Hossein Mehralizadeh; Mohammad Asghari Jafarabadi; Aymaral Ghezel; Bahram Pourghassem Gargari
Journal:  Endocrine       Date:  2017-05-16       Impact factor: 3.633

2.  Effect of Synbiotic and Probiotic Supplementation on Serum Levels of Endothelial Cell Adhesion Molecules in Hemodialysis Patients: a Randomized Control Study.

Authors:  Neda Haghighat; Majid Mohammadshahi; Shokouh Shayanpour; Mohammad Hossein Haghighizadeh
Journal:  Probiotics Antimicrob Proteins       Date:  2019-12       Impact factor: 4.609

3.  Association between omentin-1 expression in human epicardial adipose tissue and coronary atherosclerosis.

Authors:  Yu Du; Qingwei Ji; Lun Cai; Fangjiong Huang; Yongqiang Lai; Yue Liu; Jianbo Yu; Bo Han; Enjun Zhu; Jinwei Zhang; Yujie Zhou; Zhijian Wang; Yingxin Zhao
Journal:  Cardiovasc Diabetol       Date:  2016-06-28       Impact factor: 9.951

4.  Soluble vascular cell adhesion molecular-1 is a potential biological indicator of hemophilic arthropathy.

Authors:  Yu-Hsin Tseng; Shyh-Shin Chiou; Yu-Sheng Zeng; Shih-Pien Tsai; Chun-Shih Chen; Yu-Mei Liao; Pei-Chin Lin
Journal:  Medicine (Baltimore)       Date:  2016-11       Impact factor: 1.889

5.  Altered levels of blood proteins in Alzheimer's disease longitudinal study: Results from Australian Imaging Biomarkers Lifestyle Study of Ageing cohort.

Authors:  Veer Bala Gupta; Eugene Hone; Steve Pedrini; James Doecke; Sid O'Bryant; Ian James; Ashley I Bush; Christopher C Rowe; Victor L Villemagne; David Ames; Colin L Masters; Ralph N Martins
Journal:  Alzheimers Dement (Amst)       Date:  2017-04-23

6.  Circulating Omentin-1 levels and altered iron balance in chronic haemodialysis patients.

Authors:  Davide Bolignano; Evangelia Dounousi; Pierangela Presta; Marta Greco; Anila Duni; Giuseppina Crugliano; Charalambos Pappas; Ethymios Pappas; Francesco Dragone; Lampros Lakkas; Daniela Patrizia Foti; Michele Andreucci; Giuseppe Coppolino
Journal:  Clin Kidney J       Date:  2021-10-13

Review 7.  The complex effects of adipokines in the patients with kidney disease.

Authors:  Sahar Vahdat
Journal:  J Res Med Sci       Date:  2018-07-26       Impact factor: 1.852

8.  Changes in microparticle profiles by vitamin D receptor activation in chronic kidney disease - a randomized trial.

Authors:  Kristina Lundwall; Josefin Mörtberg; Fariborz Mobarrez; Stefan H Jacobson; Gun Jörneskog; Jonas Spaak
Journal:  BMC Nephrol       Date:  2019-08-01       Impact factor: 2.388

Review 9.  Association between Omentin-1 and Coronary Artery Disease: Pathogenesis and Clinical Research.

Authors:  Lutfu Askin; Hakan Duman; Ali Ozyıldız; Okan Tanriverdi; Serdar Turkmen
Journal:  Curr Cardiol Rev       Date:  2020

10.  Integrating systematic biological and proteomics strategies to explore the pharmacological mechanism of danshen yin modified on atherosclerosis.

Authors:  Kailin Yang; Liuting Zeng; Anqi Ge; Xiaoping Pan; Tingting Bao; Zhiyong Long; Qiaozhen Tong; Mengxia Yuan; Xiaofei Zhu; Jinwen Ge; Zhengde Huang
Journal:  J Cell Mol Med       Date:  2020-11-02       Impact factor: 5.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.